Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Phase 1 Recruiting 20 enrolled The Foundation for Orthopaedics and Regenerative Medicine

NaSingle-groupOpen-labelTreatment

Summary

This trial will study the safety and efficacy of cultured allogeneic adult umbilical cord derived mesenchymal stem cells delivered intravenously for the treatment of Polycystic Ovary Syndrome.

Timeline

Start: 2023-11-16
Primary completion: 2027-11-16
Completion: 2027-11-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	AlloRx	Cell therapy	2e+06 cells/kg	Intravenous

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS

Summary

Timeline

Drugs

Indications